219 related articles for article (PubMed ID: 15662118)
1. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer.
Denmeade SR; Isaacs JT
Cancer Biol Ther; 2005 Jan; 4(1):14-22. PubMed ID: 15662118
[TBL] [Abstract][Full Text] [Related]
2. Targeting thapsigargin towards tumors.
Doan NT; Paulsen ES; Sehgal P; Møller JV; Nissen P; Denmeade SR; Isaacs JT; Dionne CA; Christensen SB
Steroids; 2015 May; 97():2-7. PubMed ID: 25065587
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of thapsigargin analogues on apoptosis of prostate cancer cells: complex regulation by intracellular calcium.
Dubois C; Vanden Abeele F; Sehgal P; Olesen C; Junker S; Christensen SB; Prevarskaya N; Møller JV
FEBS J; 2013 Nov; 280(21):5430-40. PubMed ID: 23927406
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.
Denmeade SR; Jakobsen CM; Janssen S; Khan SR; Garrett ES; Lilja H; Christensen SB; Isaacs JT
J Natl Cancer Inst; 2003 Jul; 95(13):990-1000. PubMed ID: 12837835
[TBL] [Abstract][Full Text] [Related]
5. From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development.
Christensen SB; Simonsen HT; Engedal N; Nissen P; Møller JV; Denmeade SR; Isaacs JT
Prog Chem Org Nat Prod; 2021; 115():59-114. PubMed ID: 33797641
[TBL] [Abstract][Full Text] [Related]
6. Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells.
Vander Griend DJ; Antony L; Dalrymple SL; Xu Y; Christensen SB; Denmeade SR; Isaacs JT
Mol Cancer Ther; 2009 May; 8(5):1340-9. PubMed ID: 19417145
[TBL] [Abstract][Full Text] [Related]
7. Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells.
Christensen SB; Andersen A; Kromann H; Treiman M; Tombal B; Denmeade S; Isaacs JT
Bioorg Med Chem; 1999 Jul; 7(7):1273-80. PubMed ID: 10465403
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effects of sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) activator gingerol on NG115-401L neuronal cells: failure to augment ER Ca(2+) uptake and protect against ER stress-induced cell death.
Zhang C; Bose DD; Thomas DW
Eur J Pharmacol; 2015 Sep; 762():165-73. PubMed ID: 26033206
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells.
Jakobsen CM; Denmeade SR; Isaacs JT; Gady A; Olsen CE; Christensen SB
J Med Chem; 2001 Dec; 44(26):4696-703. PubMed ID: 11741487
[TBL] [Abstract][Full Text] [Related]
10. Role of endoplasmic reticulum calcium content in prostate cancer cell growth regulation by IGF and TNFalpha.
Humez S; Legrand G; Vanden-Abeele F; Monet M; Marchetti P; Lepage G; Crepin A; Dewailly E; Wuytack F; Prevarskaya N
J Cell Physiol; 2004 Nov; 201(2):201-13. PubMed ID: 15334655
[TBL] [Abstract][Full Text] [Related]
11. Presence of a thapsigargin-sensitive calcium pump in Trypanosoma evansi: Immunological, physiological, molecular and structural evidences.
Pérez-Gordones MC; Serrano ML; Rojas H; Martínez JC; Uzcanga G; Mendoza M
Exp Parasitol; 2015 Dec; 159():107-17. PubMed ID: 26297682
[TBL] [Abstract][Full Text] [Related]
12. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
Janssen S; Jakobsen CM; Rosen DM; Ricklis RM; Reineke U; Christensen SB; Lilja H; Denmeade SR
Mol Cancer Ther; 2004 Nov; 3(11):1439-50. PubMed ID: 15542783
[TBL] [Abstract][Full Text] [Related]
13. Depletion of intracellular calcium stores is toxic to SH-SY5Y neuronal cells.
Nguyen HN; Wang C; Perry DC
Brain Res; 2002 Jan; 924(2):159-66. PubMed ID: 11750901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the ER Ca2+ pump forces multidrug-resistant cells deficient in Bak and Bax into necrosis.
Janssen K; Horn S; Niemann MT; Daniel PT; Schulze-Osthoff K; Fischer U
J Cell Sci; 2009 Dec; 122(Pt 24):4481-91. PubMed ID: 19920074
[TBL] [Abstract][Full Text] [Related]
15. Secretory pathway Ca(2+)-ATPase (SPCA1) Ca(2)+ pumps, not SERCAs, regulate complex [Ca(2+)](i) signals in human spermatozoa.
Harper C; Wootton L; Michelangeli F; Lefièvre L; Barratt C; Publicover S
J Cell Sci; 2005 Apr; 118(Pt 8):1673-85. PubMed ID: 15811949
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control.
Legrand G; Humez S; Slomianny C; Dewailly E; Vanden Abeele F; Mariot P; Wuytack F; Prevarskaya N
J Biol Chem; 2001 Dec; 276(50):47608-14. PubMed ID: 11606580
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction.
Stockwin LH; Han B; Yu SX; Hollingshead MG; ElSohly MA; Gul W; Slade D; Galal AM; Newton DL; Bumke MA
Int J Cancer; 2009 Sep; 125(6):1266-75. PubMed ID: 19533749
[TBL] [Abstract][Full Text] [Related]
18. Targeted prodrug approaches for hormone refractory prostate cancer.
Aloysius H; Hu L
Med Res Rev; 2015 May; 35(3):554-85. PubMed ID: 25529338
[TBL] [Abstract][Full Text] [Related]
19. Recovery of neuronal protein synthesis after irreversible inhibition of the endoplasmic reticulum calcium pump.
Doutheil J; Treiman M; Oschlies U; Paschen W
Cell Calcium; 1999 Jun; 25(6):419-28. PubMed ID: 10579053
[TBL] [Abstract][Full Text] [Related]
20. Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.
Denmeade SR; Mhaka AM; Rosen DM; Brennen WN; Dalrymple S; Dach I; Olesen C; Gurel B; Demarzo AM; Wilding G; Carducci MA; Dionne CA; Møller JV; Nissen P; Christensen SB; Isaacs JT
Sci Transl Med; 2012 Jun; 4(140):140ra86. PubMed ID: 22745436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
